Skip to content

The unthinkable has happened: you’re a young person, and yet you’ve been diagnosed with cancer. You are parents, and your child has a tumour – maybe before they’ve even learned to walk.

All you want is for you or your child to be healthy again. You want the most effective treatment without unnecessary suffering – and without long-term consequences.

This is exactly what doctors are studying in clinical trials and research projects.

 

Trials offer the best treatment

Research doesn’t just provide insights for future patients. Participating in a trial also has direct benefits: Young patients receive treatment based on the latest scientific findings. In addition, studies always benefit from the expertise of an international panel of specialists.

The treatment team at your hospital will recommend participating in a study if one is available for your or your child’s cancer. Because treatment within a study benefits participants – and drives medical progress.

Do you have any questions? We will be happy to advise you. 

Catia Gehrig
Catia Gehrig
Head Partner Relations
+41 31 508 42 57
E-Mail

The Swiss Kids Cancer Trials platform: An overview of all clinical childhood cancer studies in Switzerland

The Swiss Kids Cancer Trials platform provides an overview of ongoing childhood cancer studies in Switzerland. In addition to SPOG studies, it also lists studies offered by other organisations. The platform is operated by SPOG and funded by the non-profit organisation Zoé4Life. It is independent, transparent and exists solely to provide information and guidance for affected families.
Explore the platform

The SPOG study portfolio

Learn more about the SPOG study portfolio: Which clinical studies and research projects are currently open for enrolment at member hospitals? Which study dossiers is SPOG currently preparing so they can be offered to affected families in Switzerland in the future?

View the SPOG study portfolio

The "SPOG Patient Advisory Board": the voice of those affected in research

SPOG conducts research on cancer in children and adolescents in Switzerland. To make sure that research reflects the needs of affected families, SPOG is supported by a patient advisory board. Adults who had cancer as children, or their relatives, share their perspective through the SPOG Patient Advisory Board (SPAB). They provide input on research projects and are available to answer questions from SPOG Coordinating Centre staff.

Paul Castle is one of the five founding members of the SPAB. In this interview, he talks about his work on the Patient Advisory Board and reveals what motivates him. Learn more

 

The members of the SPOG Patient Advisory Board (from left to right): Nicole Scobie, Claudio Nicita, Paul Castle, Nicole Seiler (Chair), Prof. Dr. med. Dr. Phil. Raffaele Renella (SPOG Board Representative), Gaëlle Solioz.

 

Do you have any questions about the SPAB or would you like to join the Patient Advisory Board?
The SPAB can have up to seven members. If you are interested in joining the Patient Advisory Board, please contact us. Dustin Singer, SPAB Project Manager at the SPOG Coordinating Centre, is looking forward to hearing from you.

Latest information